Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/30/22
End: 04/10/23
Due: 04/10/24
Phase: N/A
Priority: Normal
Start: 03/24/21
End: 10/19/21
Due: 10/19/22
Phase: N/A
Priority: Normal
Start: 03/15/22
End: 12/31/24
Due: 12/31/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Efficacy Study BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic or Pseudophakic Presbyopia | NCT05270863 | Visus Therapeutics | user2@example.com | None | 2022-03-30 | 2023-04-10 | 2024-04-10 | - | - | 2025-07-14 |
| Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia | NCT04774237 | Visus Therapeutics | user2@example.com | None | 2021-03-24 | 2021-10-19 | 2022-10-19 | - | - | 2025-07-14 |
| Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia | NCT05135286 | Visus Therapeutics | user2@example.com | None | 2022-03-15 | 2024-12-31 | 2025-12-31 | - | - | 2025-07-14 |